ihsan çakır

ihsan çakır

orcid

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
21 October 2018 in Journal of Ophthalmology
Verified
Journal Article
Open access
PDF file
AAAlper Ağca
Alper Ağca
IÇihsan çakır
ihsan çakır
BABeril Tülü Aygün
Beril Tülü Aygün
DYDilek Yaşa
Dilek Yaşa
YYYusuf Yıldırım
Yusuf Yıldırım
ADAhmet Demirok
Ahmet Demirok
Purpose. To report long-term visual and refractive results of small-incision lenticule extraction (SMILE) in treatment of high myopia. Materials and Methods. Medical records of patients who underwent SMILE for surgical correction of myopia or myopic astigmatism were retrospectively reviewed. Only patients with a preoperative spherical equivalent of subjective manifest refraction (SE) ≥ 6 D and a postoperative follow-up of 5 years were included in the study. Uncorrected distance visual acuity (UDVA), corrected distance visual acuity (CDVA), and SE were analyzed preoperatively and at 1-, 3-, and 5-year postoperative periods. Results. Thirty-seven eyes of 37 patients were included in the study. The mean attempted SE was −7.47 ± 1.10 D (range −6.00 to −10.00 D). At the 5-year visit, the mean difference between achieved and attempted SE was −0.43 ± 0.47 (0.50 to −1.25 D). Mean postoperative UDVA and CDVA were 0.20 ± 0.18 and 0.06 ± 0.08 logMAR, respectively. At the 1-year visit, 70% and 97% of the eyes were within ±0.50 D and ±1.00 D of the intended correction. At the 5-year follow-up, 59% and 92% percent of the eyes were within ±0.50 D and ±1.00 D of the intended SE, respectively. At the 5-year visit, the efficacy index was 0.89 ± 0.26 and the safety index was 1.16 ± 0.20. Fifty-four percent of the eyes gained one or more lines of CDVA. Conclusion. SMILE with an intended correction of up to a spherical equivalent of 10 D is safe and effective. However, there is regression of the refractive effect over extended follow-up.

11 March 2022 in Photodiagnosis and Photodynamic Therapy
Verified
Journal Article
Closed access
IÇihsan çakır
ihsan çakır
CACigdem Altan
Cigdem Altan
GYGulay Yalcinkaya
Gulay Yalcinkaya
MOMehmet Ozveren
Mehmet Ozveren
AKAsli Kirmaci Kabakci
Asli Kirmaci Kabakci
MTMuhittin Taskapili
Muhittin Taskapili

7 March 2023 in Journal of Cataract & Refractive Surgery
Verified
Journal Article
Closed access
IÇihsan çakır
ihsan çakır
OSOrcun Sonmez
Orcun Sonmez
SPSeren Pehlivanoglu
Seren Pehlivanoglu
GCGulay Yalcinkaya Md Cakir
Gulay Yalcinkaya Md Cakir
BYBurcin Kepez Yildiz
Burcin Kepez Yildiz
AAAlper Agca
Alper Agca
Purpose: To evaluate the long-term refractive outcomes of Eyecryl posterior chamber spherical phakic intraocular lens (pIOL) implantation in high myopia and endothelial cell density (ECD) change. Setting: Beyoglu Eye Training and Research Hospital, Istanbul, Turkey. Design: Retrospective. Methods: Eyes that were not suitable for corneal refractive surgery, had high myopia between −6.00 diopters (D) and −20.00 D, had Eyecryl posterior chamber spherical pIOL implantation, and had at least 5 years of follow-up were included. Preoperative ECD was ≥2300 cells/mm2 and cylindrical value was ≤2.0 D in all cases. Preoperative and postoperative first, third, and fifth years of refraction, uncorrected and corrected distance visual acuity (UDVA/CDVA), and ECD were recorded. Results: 36 eyes of 18 patients were examined. The mean UDVA and CDVA in postoperative fifth years were 0.24 ± 0.19 logMAR and 0.12 ± 0.18 logMAR, respectively. The safety and efficacy indices were 1.52 ± 0.54 and 1.14 ± 0.38, respectively. At 5 years, the spherical equivalent was ±0.50 D in 75% of eyes and ±1.00 D in 92% of eyes. After 5 years, the mean cumulative ECD loss was 6.91% (P = .07). The annual ECD loss was 1.57% in the first year, 0.26% between 1 year and 3 years, and 2.38% between 3 years and 5 years. Asymptomatic anterior capsule opacity developed in 1 eye 4 years after surgery. Rhegmatogenous retinal detachment developed in 1, and myopic choroidal neovascular membrane occurred in 1 eye. Conclusions: Eyecryl posterior chamber spherical pIOL implantation is one of the effective and safe refractive surgical methods in correcting high myopia with predictable and stable refractive results over a 5-year period. Longer-term studies are needed for complications such as decreased ECD, retinal complications, and lens opacity.

11 July 2024 in Indian Journal Of Ophthalmology
Verified
Journal Article
Open access
IÇihsan çakır
ihsan çakır
ABAli Safa Balci
Ali Safa Balci
NANese Alagoz
Nese Alagoz
GCGülay Yalcinkaya Cakir
Gülay Yalcinkaya Cakir
CACigdem Altan
Cigdem Altan
TYTekin Yasar
Tekin Yasar
Purpose: To compare the intraocular pressure (IOP)-lowering efficiency of gonioscopy-assisted transluminal trabeculotomy (GATT) and trabeculectomy (TRAB) with mitomycin C in patients with primary open-angle glaucoma (POAG) and pseudoexfoliative glaucoma (PEXG). Methods: In this retrospective comparative study, consecutive patients with POAG or PEXG who underwent GATT or TRAB by a single surgeon and with a follow-up period of at least 1 year were included. Surgical success rates, change in best-corrected visual acuity, IOP, the need for antiglaucoma medication, surgical complications, and the need for additional glaucoma surgery were compared. Surgical success was defined as an IOP reduction of ≥30% or an IOP of ≤18 mmHg. Complete success was defined as without medication. Qualified success was defined as with or without topical medication. Results: The mean baseline IOP was 27.4 ± 8.3 and 24.6 ± 7.6 mmHg ( P = 0.13) with the mean number of medications being 3.7 ± 1.0 and 3.7 ± 1.1 ( P = 0.98) in TRAB and GATT, respectively. At 12 months, the mean IOP was 15.3 ± 3.5 and 12.5 ± 4.6 mmHg ( P = 0.24) with the mean number of medications being 0.9 ± 1.2 and 0.8 ± 1.4 ( P = 0.76) after GATT and TRAB, respectively. IOP was lowered from baseline by 52.7% ± 17.5% after TRAB and 45.7% ±18.6% after GATT ( P = 0.12). There was no decrease in best-corrected visual acuity in either group. The qualified surgical success rate was 94.4% in the GATT group and 94.9% in the TRAB group ( P = 0.75). Percentage of complete success was 64.1% and 52.8% ( P = 0.22) after TRAB and GATT, respectively. Conclusion: In patients with POAG and PEXG, GATT was as effective and safe as TRAB in lowering IOP and reducing the number of antiglaucomatous drugs.

27 November 2021 in International Ophthalmology
Verified
Journal Article
Closed access
PDF file
GYGulay Yalcinkaya
Gulay Yalcinkaya
CACigdem Altan
Cigdem Altan
BBBerna Basarir
Berna Basarir
IÇihsan çakır
ihsan çakır

1 March 2022 in Photodiagnosis and Photodynamic Therapy
Verified
Journal Article
Closed access
IÇihsan çakır
ihsan çakır
CACigdem Altan
Cigdem Altan
GYGulay Yalcinkaya
Gulay Yalcinkaya
NANese Alagoz
Nese Alagoz
BSBanu Solmaz
Banu Solmaz
TYTekin Yasar
Tekin Yasar